PedAM
Pediatric Disease Annotations & Medicines
| Disease | lung disease |
| Phenotype | |hypertension |
| Sentences | 55 |
| PubMedID- 26029570 | We also present a review of the literature on treatment of pulmonary hypertension in patients with chronic lung disease. |
| PubMedID- 21693294 | Effect of pulmonary hypertension in patients with end-stage lung disease on posttransplantation outcomes. |
| PubMedID- 23407895 | Assessing pulmonary arterial hypertension in infants with severe chronic lung disease of infancy: a role for a pulmonary artery catheter. |
| PubMedID- 22936711 | We assessed the safety, tolerability and preliminary efficacy of riociguat, a soluble guanylate cyclase stimulator, in patients with pulmonary hypertension associated with interstitial lung disease (ph-ild). |
| PubMedID- 20522579 | Pulmonary hypertension (ph) associated with parenchymal lung diseases is one of the most common forms of ph. |
| PubMedID- 20421106 | Pulmonary arterial hypertension in infants with chronic lung disease: will we ever understand it. |
| PubMedID- 24027689 | In recent years, the use of ino for “off-label” indications, such as for rescue treatment of preterm infants with severe respiratory failure, babies with severe chronic lung disease complicated by pulmonary hypertension and for prevention of bronchopulmonary dysplasia (bpd) has increased greatly. |
| PubMedID- 25613108 | Role of bnp and echo measurement for pulmonary hypertension recognition in patients with interstitial lung disease: an algorithm application model. |
| PubMedID- 24982101 | Pulmonary arterial hypertension (pah) associated with chronic lung disease of infancy can be a life-threatening disease affecting an increasing number of former premature infants. |
| PubMedID- 23920210 | Background: pulmonary hypertension is frequently associated with parenchymal lung disease. |
| PubMedID- 21536179 | Pulmonary hypertension associated with chronic infiltrative lung diseases can be detected by echocardiography and must be confirmed by right-sided heart catheterization, especially to rule out post-capillary pulmonary hypertension frequent in this context. |
| PubMedID- 24267299 | Pulmonary hypertension due to lung disease and/or hypoxia. |
| PubMedID- 26453478 | Purpose: recent imaging studies demonstrated the usefulness of quantitative computed tomographic (ct) analysis assessing pulmonary hypertension (ph) in patients with chronic obstructive lung disease (copd-ph). |
| PubMedID- 24697923 | Haemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with pde-5 inhibitors. |
| PubMedID- 22958673 | Patients with lung diseases associated with pre-existing pulmonary hypertension (mean pap > 25 mm hg at rest) are advised against high altitude travel. |
| PubMedID- 25046428 | Pulmonary hypertension associated with chronic obstructive lung disease and idiopathic pulmonary fibrosis. |
| PubMedID- 26029619 | Some patients with group 3 pulmonary hypertension (ph) (ph due to lung disease and/or hypoxia) exhibit disproportionately advanced or "out-of-proportion" ph. |
| PubMedID- 23797369 | We tested whether sscpah or systemic sclerosis-related pulmonary hypertension with interstitial lung disease imposes a greater pulmonary vascular load than ipah and leads to worse rv contractile function. |
| PubMedID- 26115628 | The treatment of choice for patients who are hypoxemic and have pulmonary hypertension associated with chronic lung disease is long-term oxygen therapy. |
| PubMedID- 26283756 | Objectives: this study was conducted to evaluate the value of sonographic b-lines (previously called "comet tail artifacts") in assessment of pulmonary hypertension in patients with interstitial lung diseases. |
| PubMedID- 21538327 | Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies. |
| PubMedID- 24671311 | Polysomnographic differences associated with pulmonary hypertension in patients with advanced lung disease due to cystic fibrosis. |
| PubMedID- 26166793 | Pulmonary hypertension in the course of diffuse parenchymal lung diseases - state of art and future considerations. |
| PubMedID- 23354416 | Pulmonary hypertension is often associated with inflammatory lung diseases, for example chronic obstructive pulmonary disease, or autoimmune diseases. |
| PubMedID- 23271856 | We report a scd patient who presented with ct proven interstitial lung disease complicated by pulmonary hypertension and cor pulmonale. |
| PubMedID- 25954555 | Despite aggressive intervention, he continued to be ventilator dependent with worsening pulmonary hypertension due to chronic lung disease. |
| PubMedID- 25183617 | We report the case of a 75-years-old man who diagnosed with severe pulmonary hypertension, associated with interstitial lung disease characterized by a rapid and fatal outcome. |
| PubMedID- 26473476 | However, our study could not adjust for pulmonary hypertension, a complication of interstitial lung disease, including idiopathic lung fibrosis. |
| PubMedID- 26293503 | Pulmonary hypertension (ph) due to lung disease (world health organization (who) group 3) is common, but severe ph, arbitrarily defined as mean pulmonary artery pressure >/=35 mmhg is reported in only a small proportion. |
| PubMedID- 22701211 | In summary, it was a challenging case to manage in view of the ards and her past history of diabetes mellitus, hypertension, sarcoidosis with interstitial lung disease, copd, recurrent ventricular tachycardia and obesity. |
| PubMedID- 21182801 | In general, the severity of pulmonary hypertension due to lung diseases and/or hypoxia is usually from mild to moderate compared with pah [4,10]. |
| PubMedID- 21941650 | Who group 3 includes pulmonary hypertension that occurs with chronic lung diseases such as emphysema, interstitial lung disease, and sleep disordered breathing. |
| PubMedID- 23841910 | Severe obstructive lung disease with pulmonary hypertension may be a contraindication for lung flooding. |
| PubMedID- 26361668 | Pulmonary hypertension (ph) associated with lung diseases not only is an index of poor outcome but also is an indication for bilateral procedure. |
| PubMedID- 23884296 | Pulmonary arterial hypertension, pulmonary hypertension due to lung disease, or chronic thromboembolic pulmonary hypertension; phpvd), from those with left heart disease associated pulmonary hypertension (pulmonary venous hypertension; pvh) is crucial as workup and treatment options differ dramatically. |
| PubMedID- 21266048 | Background: chronic alveolar hypoxia, due to residence at high altitude or chronic obstructive lung diseases, leads to pulmonary hypertension, which may be further complicated by right heart failure, increasing morbidity and mortality. |
| PubMedID- 22415303 | Little is known regarding the cellular and molecular mechanisms that lead to pulmonary hypertension in patients with interstitial lung disease, and effective treatment options are lacking. |
| PubMedID- 20920139 | The use of sildenafil to treat pulmonary hypertension associated with interstitial lung disease. |
| PubMedID- 19818095 | However, whether osa directly causes sustained daytime pulmonary hypertension in the absence of co-existing chronic lung disease or obesity-related hypoventilation is debated. |
| PubMedID- 21474572 | Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease. |
| PubMedID- 20819757 | Chronic hypoxia is the major mechanism implicated for the development of pulmonary hypertension in patients with lung diseases. |
| PubMedID- 20092992 | Pulmonary hypertension in lung diseases: survey of beliefs and practice patterns. |
| PubMedID- 25076998 | Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: pulmonary hypertension due to lung diseases and/or hypoxia. |
| PubMedID- 22221973 | Pulmonary hypertension due to chronic lung disease: updated recommendations of the cologne consensus conference 2011. |
| PubMedID- 25006405 | Tada-phild (tadalafil for pulmonary hypertension associated with chronic obstructive lung disease) is the first sufficiently powered randomized clinical trial testing the effect of pde-5i on key clinical and drug safety outcome measures in patients with at least moderate ph due to copd. |
| PubMedID- 25813769 | Background: pulmonary hypertension associated with lung disease (phld) has been shown to be a predictor of disease severity and survival in patients awaiting lung transplantation. |
| PubMedID- 20862620 | [pulmonary hypertension due to chronic lung disease. |
| PubMedID- 23009908 | Pulmonary hypertension in the setting of parenchymal lung disease and conditions associated with chronic hypoxemia is commonly encountered in clinical practice and may adversely affect patients' function and mortality. |
| PubMedID- 21719760 | Rationale: senescence of pulmonary artery smooth muscle cells (pa-smcs) caused by telomere shortening or oxidative stress may contribute to pulmonary hypertension associated with chronic lung diseases. |
| PubMedID- 22065320 | Pre-capillary ph is defined as a wedge pressure <15 mmhg and can be divided into pulmonary arterial hypertension, ph due to lung disease, chronic thromboembolic ph or ph with unclear and/or multifactorial mechanisms. |
Page: 1 2